BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35078530)

  • 1. An application of PRECIS-2 to evaluate trial design in a pilot cluster randomised controlled trial of a community-based smoking cessation intervention for women living in disadvantaged areas of Ireland.
    Darker C; Loudon K; O'Connell N; Castello S; Burke E; Vance J; Reynolds C; Buggy A; Dougall N; Williams P; Dobbie F; Bauld L; Hayes CB
    Pilot Feasibility Stud; 2022 Jan; 8(1):19. PubMed ID: 35078530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. We Can Quit2 (WCQ2): a community-based intervention on smoking cessation for women living in disadvantaged areas of Ireland-study protocol for a pilot cluster randomised controlled trial.
    Hayes C; Ciblis A; Darker C; Dougall N; Vance J; O'Connell N; Dobbie F; Loudon K; Burke E; Devane D; Bauld L
    Pilot Feasibility Stud; 2019; 5():138. PubMed ID: 31788324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peer-Delivery of a Gender-Specific Smoking Cessation Intervention for Women Living in Disadvantaged Communities in Ireland We Can Quit2 (WCQ2)-A Pilot Cluster Randomized Controlled Trial.
    Hayes CB; Patterson J; Castello S; Burke E; O'Connell N; Darker CD; Bauld L; Vance J; Ciblis A; Dobbie F; Loudon K; Devane D; Dougall N
    Nicotine Tob Res; 2022 Mar; 24(4):564-573. PubMed ID: 34939119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot cluster randomised controlled trial of a peer-delivered outreach community-based smoking cessation intervention for women living in disadvantaged communities in Ireland.
    Hayes CB; Patterson J; Castello S; Burke E; O'Connell N; Darker C; Vance J; Bauld L; Dobbie F; Loudon K; Devane D; Dougall N
    Rural Remote Health; 2023 Jan; 23(1):8163. PubMed ID: 36802719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A process evaluation of 'We Can Quit': a community-based smoking cessation intervention targeting women from areas of socio-disadvantage in Ireland.
    Darker CD; Burke E; Castello S; O'Sullivan K; O'Connell N; Vance J; Reynolds C; Buggy A; Dougall N; Loudon K; Williams P; Dobbie F; Bauld L; Hayes CB
    BMC Public Health; 2022 Aug; 22(1):1528. PubMed ID: 35948970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.
    Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL
    Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot randomised trial to assess the methods and procedures for evaluating the clinical effectiveness and cost-effectiveness of Exercise Assisted Reduction then Stop (EARS) among disadvantaged smokers.
    Taylor AH; Thompson TP; Greaves CJ; Taylor RS; Green C; Warren FC; Kandiyali R; Aveyard P; Ayres R; Byng R; Campbell JL; Ussher MH; Michie S; West R
    Health Technol Assess; 2014 Jan; 18(4):1-324. PubMed ID: 24433837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service.
    Peckham E; Man MS; Mitchell N; Li J; Becque T; Knowles S; Bradshaw T; Planner C; Parrott S; Michie S; Shepherd C; Gilbody S
    Health Technol Assess; 2015 Mar; 19(25):1-148, v-vi. PubMed ID: 25827850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating pragmatic and implementation science randomized clinical trial approaches: a PRagmatic Explanatory Continuum Indicator Summary-2 (PRECIS-2) analysis.
    Zatzick D; Palinkas L; Chambers DA; Whiteside L; Moloney K; Engstrom A; Prater L; Russo J; Wang J; Abu K; Iles-Shih M; Bulger E
    Trials; 2023 Apr; 24(1):288. PubMed ID: 37085877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.
    Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM
    Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory.
    Johnson KE; Neta G; Dember LM; Coronado GD; Suls J; Chambers DA; Rundell S; Smith DH; Liu B; Taplin S; Stoney CM; Farrell MM; Glasgow RE
    Trials; 2016 Jan; 17():32. PubMed ID: 26772801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing provider-focused implementation trials with purpose and intent: introducing the PRECIS-2-PS tool.
    Norton WE; Loudon K; Chambers DA; Zwarenstein M
    Implement Sci; 2021 Jan; 16(1):7. PubMed ID: 33413489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How pragmatic or explanatory is the randomized, controlled trial? The application and enhancement of the PRECIS tool to the evaluation of a smoking cessation trial.
    Selby P; Brosky G; Oh PI; Raymond V; Ranger S
    BMC Med Res Methodol; 2012 Jul; 12():101. PubMed ID: 22824225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facing the Realities of Pragmatic Design Choices in Environmental Health Studies: Experiences from the Household Air Pollution Intervention Network Trial.
    Checkley W; Hossen S; Rosa G; Thompson LM; McCracken JP; Diaz-Artiga A; Balakrishnan K; Simkovich SM; Underhill LJ; Nicolaou L; Hartinger SM; Davila-Roman VG; Kirby MA; Clasen TF; Rosenthal J; Peel JL; On Behalf Of Household Air Pollution Intervention Network Hapin Investigators
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT.
    Peckham E; Arundel C; Bailey D; Crosland S; Fairhurst C; Heron P; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C; Gilbody S
    Health Technol Assess; 2019 Sep; 23(50):1-116. PubMed ID: 31549622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced psychological care in cardiac rehabilitation services for patients with new-onset depression: the CADENCE feasibility study and pilot RCT.
    Richards SH; Campbell JL; Dickens C; Anderson R; Gandhi M; Gibson A; Kessler D; Knight L; Kuyken W; Richards DA; Taylor RS; Turner K; Ukoumunne OC; Davey A; Warren FC; Winder RE; Wright CA
    Health Technol Assess; 2018 May; 22(30):1-220. PubMed ID: 29856312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRECIS-2 analysis of pragmatic acupuncture trials: a systematic review.
    Lim J; Lee H; Kim YS
    BMC Complement Med Ther; 2024 May; 24(1):181. PubMed ID: 38702632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How pragmatic are the randomised trials used in recommendations for control of glycosylated haemoglobin levels in type 2 diabetic patients in general practice: an application of the PRECIS II tool.
    Ettori-Ajasse I; Tatin E; Forbes G; Eldridge S; Dibao-Dina C
    Trials; 2020 Mar; 21(1):281. PubMed ID: 32188470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot and feasibility studies for pragmatic trials have unique considerations and areas of uncertainty.
    Chan CL; Taljaard M; Lancaster GA; Brehaut JC; Eldridge SM
    J Clin Epidemiol; 2021 Oct; 138():102-114. PubMed ID: 34229091
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.